Therapy of ventricular tachycardia in patients with nonischemic cardiomyopathies

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 7, 1996, Pages 671-683

  Blanck, Zalmen ^a,b   Akhtar, Masood ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; PROCAINAMIDE;

CARDIOMYOPATHY; CATHETER ABLATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HIS BUNDLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; PURKINJE FIBER; RADIOFREQUENCY; REENTRY TACHYCARDIA; REVIEW;

EID: 0029896910     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00574.x     Document Type: Review

References (66)

1. Richardson P, McKenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
2. Lo YSA, Billingham M, Rowan RA, et al: Histopathologic and electrophysiologic correlations in idiopathic dilated cardiomyopathy and sustained ventricular tachycardia. Am J Cardiol 1989;64:1063-1066.
3. Caceres J, Jazayeri M, McKinnie J, et al: Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 1989;79:256-270.
4. Blanck Z, Dhala A, Deshpande S, et al: Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients. J Cardiovasc Electrophysiol 1993;4:253-262.
5. Huang SK, Messer JV, Denes P: Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients. Am J Cardiol 1983;51:507-512.
6. Kjekshus J: Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:421-481.
7. Brembilla-Perrot B, Donetti J, Terrier de la Chaise A, et al: Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991;121:1124-1131.
8. Meinertz T, Teese N, Kasper W, et al: Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol 1985;56:337-341.
9. Middlekauff HR, Stevenson WG, Woo MA, et al: Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemie cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol 1990;66:1113-1117.
10. Mancini DM, Wong KL, Simson MB: Prognostic value of an abnormal signal-average electrocardiogram in patients with non-ischemic congestive cardiomyopathy. Circulation 1993;87:1083-1092.
11. Middlekauff HR, Stevenson WG, Stevenson LW, et al: Syncope in advanced heart failure: High risk of sudden death regardless of syncope origin. Am Heart J 1992;21:110-116.
12. Saumarez RC, Slade AKB, Grace AA, et al: The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation 1995;91:2762-2768.
13. Hasumi M, Sekiguchi M, Hiroe M, et al: Endomyocardial biopsy approach to patients with ventricular tachycardia with special reference to arrhythmogenic right ventricular dysplasia. Jpn Circ J 1987;51:242-249.
14. Fontaine G, Fontaliran F, Iwa T, et al: Arrhythmogenic right ventricular dysplasia: Definition and mechanism of sudden death. In Akhtar M, Myerburg R, Ruskin J, eds: Sudden Cardiac Death: Prevalence, Mechanisms, and Approaches to Diagnosis and Management. Williams & Wilkins, Malvern, PA, 1994, pp. 226-237.
15. Winters SL, Cohen M, Greenberg S, et al: Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-943.
16. Oliveira JSM, Oliveira JAM, Frederigue U Jr, et al: Apical aneurysm of Chagas's heart disease. Br Heart J 1981;46:432-437.
17. Acquatella H, Catalioti F, Gomez-Mancebo JR, et al: Long-term control of Chagas disease in Venezuela: Effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation 1987;76: 556.
18. Blanck Z, Jazayeri M, Akhtar M: Facilitation of sustained bundle branch reentrant ventricular tachycardia by atrial fibrillation. J Cardiovasc Electrophysiol 1996; 7:348-352.
19. Tchou P, Blanck Z, McKinnie J, et al: Mechanism of inducible ventricular tachycardia in patients with idiopathic dilated cardiomyopathy. (Abstract) Circulation 1989;13:174.
20. Tchou P, Jazayeri M, Denker S, et al: Transcatheter electrical ablation of the right bundle branch: A method of treating macro-reentrant ventricular tachycardia due to bundle branch reentry. Circulation 1988;76:246-257.
21. Cohen T, Chien W, Lurie K, et al: Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: Results and long-term follow-up. J Am Coll Cardiol 1991;18:1767-1773.
22. Blanck Z, Deshpande S, Jazayeri M, et al: Catheter ablation of the left bundle branch for the treatment of sustained bundle branch reentrant ventricular tachycardia. J Cardiovasc Electrophysiol 1995;6:40-43.
23. Crijns HJGM, Smeets JLRM, Rodrigues LM, et al: Cure of interfascicular reentrant tachycardia by ablation of the anterior fascicle of the left bundle branch. J Cardiovasc Electrophysiol 1995;6:486-492.
24. Berger RD, Ories D, Kasper EK, et al: Catheter ablation of coexistent bundle branch and interfascicular reentrant ventricular tachycardias. J Cardiovasc Electrophysiol 1996;7:341-347.
25. Chen WW, Scheinman MM, Cohen TJ, et al: Importance of recording the right bundle branch deflection in the diagnosis of His-Purkinje reentrant tachycardia. PACE 1992;15:1015-1024.
26. Stevenson WG, Middlekauff HM, Stevenson LW, et al: Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure. Am Heart J 1992;124:123-130.
27. Liem LB, Swerdlow CD: Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988;62:611-616.
28. Poll DS, Marchlinski FE, Buxton AE, et al: Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: Electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984;70:451-456.
29. Milner PG, DiMarco JP, Lerman BB: Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988;11:562-568.
30. Poll DS, Marchlinski FE, Buxton AE, et al: Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:992-997.
31. Skale BT, Miles WM, Heger JJ, et al: Survivors of cardiac arrest: Prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Am J Cardiol 1986;57:113-119.
32. Swerdlow CD, Winkle RA, Mason JW: Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983;24:1436-1442.
33. The CASCADE Investigators: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (The CASCADE study). Am J Cardiol 1993;72:280-287.
34. Herre JM, Sauve MJ, Malone P, et al: Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989;13:442-449.
35. Tamburro P, Wilber D: Sudden death in idiopathic cardiomyopathy. Am Heart J 1992;124:1035-1045.
36. Singh SN, Gross-Fisher S, Fletcher RD, et al: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med 1995;33:77-82.
37. Doval HC, Nul DR, Vancelli HO, et al: Randomized trial of low-dose amiodarone in congestive heart failure. Lancet 1994;344:493-498.
38. CIBIS Investigators and Committees: A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-1773.
39. Pressler ML, Carson PE, Miller AB, et al., for the PRAISE Investigators: Safety of amlopidine in severe heart failure: Reduction of sudden death in non-ischemic heart disease. J Am Coll Cardiol 1996;27:281A.
40. Lehmann M, Steinman RT, Shuger CP, et al: The automatic implantable cardioverter-defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-805.
41. Winkle RA, Mead RH, Ruder MA, et al: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-1361.
42. Thomas AC, Moser SA, Smutka ML, et al: Implantable defibrillation: Eight years clinical experience. PACE 1988;11:2053-2058.
43. Lessmeier TJ, Lehmann MH, Steinman RT, et al: Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction. Am J Cardiol 1993;72:911-915.
44. Borggrefe M, Chen X, Martinez-Rubio A, et al: The role of implantable cardioverter-defibrillators in dilated cardiomyopathy. Am Heart J 1994;127:1145-1150.
45. Fazio G, Veltri EP, Tomaselli G, et al: Long-term follow-up of patients with non-ischemic cardiomyopathy and ventricular tachyarrhythmias treated with implantable cardioverter-defibrillators. PACE 1991;14: 1905-1910.
46. Tchou PJ, Krebs AC, Sra J, et al: Syncope: A warning sign of sudden death in idiopathic dilated cardiomyopathy patients. (Abstract) J Am Coll Cardiol 1991;17:196.
47. Newman D, Sauve MJ, Herre J, et al: Survival after implantation of the cardioverter-defibrillator. Am J Cardiol 1992;62:899-903.
48. Wever EFD, Hauer RNW, van Capelle FJL, et al: Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in post-in-farct sudden death survivors. Circulation 1995;91: 2195-2203.
49. Kuck KH, Siebels J, Schneider M, et al., and the Hamburg Cardiac Arrest Study group. Preliminary results of a randomized trial. AICD versus drugs. (Abstract) Rev Eur Tech Biomed 1990;12:110.
50. Kottkamp H, Hindricks G, Chen X, et al: Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 1995;92:1159-1168.
51. Nicod P, Polikar R, Peterson KL: Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988;318:1255-1256.
52. Alfonso F, Frenneaux M, McKenna WJ: Clinical sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular aneurysm. Br Heart J 1989;61:178-181.
53. Fananapazir L, Tracy C, Leon MB: Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: A consecutive analysis of 155 patients. Circulation 1989;80:1259-1268.
54. Fananapazir L, Epstein ND, Curiel RV: Long-term results of pacing in obstructive cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742.
55. McIntosh CL, Maron BJ: Current operative treatment of hypertrophic cardiomyopathy. Circulation 1988; 78:487-495.
56. Fananapazir L, Leon MB, Bonow RO, et al: Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. Am J Cardiol 1991;67:175-182.
57. Olsson SB, Edvarsson N, Emanuelsson H, et al: A case of arrhythmogenic right ventricular dysplasia with ventricular fibrillation. Clin Cardiol 1982;5:591-596.
58. Marcus FI, Fontaine G, Frank R, et al: Long term follow-up in patients with arrhythmogenic right ventricular disease. Eur Heart J 1989;10(Suppl D):68-73.
59. Shoda M, Kasanuki H, Ohnishi S, et al: Recurrence of new ventricular tachycardia after successful catheter ablation in patients with arrhythmogenic right ventricular dysplasia. (Abstract) Circulation 1992;86:580.
60. Marcus FI, Fontaine G: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. PACE 1995; 18:1298-1314.
61. Asso A, Farre J, Zayas R, et al: Radiofrequency catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia. (Abstract) J Am Coll Cardiol 1994;25:315.
62. Stewart RE, Graham DM, Godfrey GW, et al: Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J 1988;115:1324-1326.
63. Chiale PA, Halpern MS, Nau GJ, et al: Malignant ventricular arrhythmias in chronic chagasic myocarditis. PACE 1982;5:162-172.
64. Giniger A, Retyk EO, Laino RA, et al: Ventricular tachycardia in Chagas disease. Am J Cardiol 1992; 70:459-462.
65. Mendoza I, Camardo J, Moleiro F, et al: Sustained ventricular tachycardia in chronic Chagasic myocarditis: Electrophysiologic and pharmacologic characteristics. Am J Cardiol 1986;57:423-427.
66. Saxon LA, Stevenson WG, Middlekauff HR, et al: Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993;72:62-65.